Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiopurines with Low-Dose Allopurinol Crossover Study
2016-001638-84Phase 4Completed
- Sponsor
- Meander Medical Center
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of allopurinol in Crohn's disease and autoimmune colitis, sponsored by Meander Medical Center. Primary endpoints: 6-thioguanine nucleotide (6-TGN) concentration and 6-methylmercaptopurine (6-MMP) concentration. Started May 2016; status: completed.
02
Drugs
allopurinol
03
Conditions
Crohn's diseaseautoimmune colitis
Beyond the preview
Go deeper on 2016-001638-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001638-84.